Terms ending in 2035
Every in-force patent on Exosome Diagnostics, Inc.'s record whose computed term ends in 2035, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 11,268,085 | Methods for Isolating Microvesicles and Extracting Nucleic Acids from Biological Samples In force · High confidence | Exact Sciences Corporation | In force | High confidence | |
| US 10,301,681 | Methods of Treating a Subject with a High Gleason Score Prostate Cancer In force · High confidence | Exosome Diagnostics, Inc. | In force | High confidence | |
| US 10,465,183 | Methods for Isolating Microvesicles and Extracting Nucleic Acids from Biological Samples In force · High confidence | Exact Sciences Corporation | In force | High confidence |
3 of 3 patents shown. Soonest term end first, then patent number.
1 of these is in force and held by Exosome Diagnostics, Inc..
Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.